Deutsche Bank Ag\ Paratek Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.73 - $3.09 $48,630 - $86,859	-28,110 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.94 - $4.77 $9,284 - $15,063	-3,158 Reduced 10.1%	28,110 $83,000
Q4 2021 Feb 11, 2022	BUY	$4.07 - $5.3 $6,129 - $7,981	1,506 Added 5.06%	31,268 $141,000
Q3 2021 Nov 04, 2021	SELL	$4.7 - $7.24 $915,677 - $1.41 Million	-194,825 Reduced 86.75%	29,762 $145,000
Q2 2021 Aug 11, 2021	SELL	$6.81 - $10.93 $109,028 - $174,989	-16,010 Reduced 6.65%	224,587 $1.53 Million
Q1 2021 May 13, 2021	BUY	$6.14 - $8.31 $372,286 - $503,860	60,633 Added 33.69%	240,597 $1.7 Million
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $270,435 - $421,595	-59,047 Reduced 24.7%	179,964 $1.13 Million
Q3 2020 Nov 12, 2020	BUY	$4.19 - $6.69 $581,060 - $927,755	138,678 Added 138.22%	239,011 $1.29 Million
Q2 2020 Aug 13, 2020	BUY	$2.97 - $5.22 $264,285 - $464,501	88,985 Added 784.15%	100,333 $524,000
Q1 2020 May 14, 2020	SELL	$2.67 - $4.97 $1,788 - $3,329	-670 Reduced 5.57%	11,348 $36,000
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $8,672 - $13,320	2,960 Added 32.68%	12,018 $47,000
Q3 2019 Nov 14, 2019	SELL	$3.08 - $5.76 $268,560 - $502,243	-87,195 Reduced 90.59%	9,058 $38,000
Q2 2019 Aug 14, 2019	SELL	$3.47 - $6.32 $756,054 - $1.38 Million	-217,883 Reduced 69.36%	96,253 $381,000
Q1 2019 May 15, 2019	SELL	$5.36 - $7.24 $13,534 - $18,281	-2,525 Reduced 0.8%	314,136 $1.68 Million
Q4 2018 Feb 14, 2019	BUY	$4.8 - $11.6 $158,092 - $382,057	32,936 Added 11.61%	316,661 $1.62 Million
Q3 2018 Dec 21, 2021	BUY	$9.05 - $10.95 $116,211 - $140,608	12,841 Added 4.74%	283,725 $2.75 Million
Q3 2018 Nov 14, 2018	SELL	$9.05 - $10.95 $2.79 Million - $3.38 Million	-308,449 Reduced 53.24%	270,884 $2.63 Million
Q2 2018 Apr 21, 2020	BUY	$10.2 - $13.9 $158,375 - $215,825	15,527 Added 2.75%	579,333 $5.91 Million
Q2 2018 Aug 14, 2018	BUY	$10.2 - $13.9 $660,501 - $900,094	64,755 Added 12.98%	563,806 $5.75 Million
Q1 2018 Oct 18, 2019	BUY	$12.65 - $18.85 $154,481 - $230,196	12,212 Added 2.51%	499,051 $6.49 Million
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $1.4 Million - $2.08 Million	110,554 Added 29.38%	486,839 $6.33 Million
Q4 2017 Feb 14, 2018	SELL	$17.45 - $25.6 $348,808 - $511,718	-19,989 Reduced 5.04%	376,285 $6.73 Million
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $7.49 Million - $11.2 Million	396,274	396,274 $9.94 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account